At Aoxing, we value partnerships. Our history has proven-and our strategy continues to prove-that by working together, we can discover, develop, and deliver the innovative pharmaceutical therapies that will help people live longer, healthier, and more active lives.
Global Strategy
American Oriental Bioengineering, Inc. (NYSE: AOB) - We entered into a Joint Strategic Alliance with American Oriental Bioengineering, Inc. in March 2008 in co-development and marketing of narcotic drug products in China.
China National Institute on Drug Dependence -We also entered into clinical stage strategic partnership with Chinese National Institute on Drug Dependence at Beijing Univerisity in developing new generation of safe and effective treatment for opioid addition.
Collaborative Vision
We seek the best ideas, capabilities, and research available, whatever the source. Having excellent in-house talent and resources is one of the pillars of our R&D success, but at the same time, we're excited about the opportunities that exist to collaborate. Great work is being done in all corners of the world and in multiple settings. Our goal is to find it, advance it, and put it to work for the patients who need it.
Straightforward Approach
We think the best way to establish a relationship is through a clear, straightforward process that enables us to respond rapidly and efficiently to potential partnering opportunities. And as the first China pharma company to establish an office of alliance management in the USA, we continue to devote dedicated, experienced teams to ensure partnership success.
Business Partnership Contact
Aoxing Pharmaceutical Company, Inc
15 Exchange Place, Suite 500
Jersey City, NJ 07302
Tel:646-367-1747
E-mail: Chinaaoxing@gmail.com
Partnerships